5060 POSTER Albumin-bound Paclitaxel (ab-pac) Versus Docetaxel for First-line Treatment of Metastatic Breast Cancer (MBC): Overall Survival (OS) Subset Analyses of a Randomized Phase 2 Trial

5060 POSTER Albumin-bound Paclitaxel (ab-pac) Versus Docetaxel for First-line Treatment of Metastatic Breast Cancer (MBC): Overall Survival (OS) Subset Analyses of a Randomized Phase 2 Trial

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) Vol. 47; p. S348
Main Authors: Gradishar, W.J, Krasnojon, D.A, Cheporov, S.V, Makhson, A.N, Manikhas, G.M, Clawson, A, Bhar, P
Format: Journal Article
Language:English
Published: Elsevier Ltd 2011
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(11)71502-7